Evidence of T-cell recognition in mice of a purified lipophosphoglycan from Leishmania major
- PMID: 2807527
- PMCID: PMC259819
- DOI: 10.1128/iai.57.11.3349-3356.1989
Evidence of T-cell recognition in mice of a purified lipophosphoglycan from Leishmania major
Abstract
We have previously reported that a Leishmania major lipophosphoglycan (LPG), given with killed Corynebacterium parvum as an adjuvant, can vaccinate mice against cutaneous leishmaniasis. In order to analyze whether T cells are able to recognize this important parasite antigen, we have studied both humoral and cellular immune responses to L. major LPG that had been isolated from promastigotes by sequential solvent extraction and hydrophobic chromatography. The data show that immunization of mice with highly purified LPG induced an increase in frequency of L. major-reactive T cells and the production of immunoglobulin G antibodies to LPG. Furthermore, genetically resistant mice infected with L. major were able to develop a specific delayed-type hypersensitivity response in the ear to L. major LPG. These findings strongly suggest that T cells can recognize and respond to glycolipid antigens, in this case a host-protective Leishmania LPG, even though such antigens appear not to be potent T-cell stimulators in mice.
Similar articles
-
T-cell reactivity to purified lipophosphoglycan from Leishmania major: a model for analysis of the cellular immune response to microbial carbohydrates.Behring Inst Mitt. 1991 Feb;(88):161-9. Behring Inst Mitt. 1991. PMID: 2049034 Review.
-
Cellular and humoral immune responses in a population from the Baringo District, Kenya to Leishmania promastigote lipophosphoglycan.Am J Trop Med Hyg. 1992 Apr;46(4):480-8. doi: 10.4269/ajtmh.1992.46.480. Am J Trop Med Hyg. 1992. PMID: 1575296
-
Activation of human T lymphocytes by Leishmania lipophosphoglycan.Scand J Immunol. 1991 Feb;33(2):219-24. doi: 10.1111/j.1365-3083.1991.tb03752.x. Scand J Immunol. 1991. PMID: 1902000
-
Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.Parasit Vectors. 2016 Oct 6;9(1):532. doi: 10.1186/s13071-016-1807-8. Parasit Vectors. 2016. PMID: 27716391 Free PMC article.
-
[Parasitic evasion mechanisms: Leishmania as an example].Immun Infekt. 1989 Aug;17(4):129-40. Immun Infekt. 1989. PMID: 2673994 Review. German.
Cited by
-
Analysis of the human T cell responsiveness to purified antigens of Leishmania: lipophosphoglycan (LPG) and glycoprotein 63 (gp 63).Clin Exp Immunol. 1991 Mar;83(3):472-8. doi: 10.1111/j.1365-2249.1991.tb05663.x. Clin Exp Immunol. 1991. PMID: 2004486 Free PMC article.
-
Interleukin-4 but not gamma interferon production correlates with the severity of murine cutaneous leishmaniasis.Infect Immun. 1993 Aug;61(8):3459-65. doi: 10.1128/iai.61.8.3459-3465.1993. Infect Immun. 1993. PMID: 8335376 Free PMC article.
-
Synthetic neoglycoconjugates of cell-surface phosphoglycans of Leishmania as potential anti-parasite carbohydrate vaccines.Biochemistry (Mosc). 2011 Jul;76(7):761-73. doi: 10.1134/S0006297911070066. Biochemistry (Mosc). 2011. PMID: 21999537 Free PMC article. Review.
-
Carbohydrate vaccines: developing sweet solutions to sticky situations?Nat Rev Drug Discov. 2010 Apr;9(4):308-24. doi: 10.1038/nrd3012. Nat Rev Drug Discov. 2010. PMID: 20357803 Free PMC article. Review.
-
A Ferrier glycosylation/cis-dihydroxylation strategy to synthesize Leishmania spp. lipophosphoglycan-associated βGal(1,4)Man disaccharide.RSC Adv. 2022 Oct 4;12(43):28207-28216. doi: 10.1039/d2ra05158c. eCollection 2022 Sep 28. RSC Adv. 2022. PMID: 36320230 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources